EUVIMEDEUVIMED entdecken
Crossref

Dosimetric impact of androgen deprivation therapy (ADT)-induced prostate deformation in low-dose-rate prostate brachytherapy

Younghun Yoon, Wooshik Kim, Han-Back Shin, Jihun Kim, Jaeho Cho

Brachytherapy · 2026

DOI: 10.1016/j.brachy.2025.11.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brachytherapy, 2026. Verfasst von Younghun Yoon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, South Kor…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Androgen Antagonists, Prostate. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Androgen deprivation therapy (ADT) for prostate cancer typically reduces prostate volume. This study investigated how the timing of ADT relative to low-dose-rate (LDR) brachytherapy influences the resulting dosimetric outcomes. METHODS: Using deformable image registration and principal component analysis on pre- and post-ADT magnetic resonance images of 34 patients, we developed a statistical model of ADT-induced prostate deformation. We applied this model to 30 low-dose-rate (LDR) brachytherapy plans (prescription dose: 145 Gy) to simulate seed displacement and dose distribution changes from prostate shrinkage. Prostate deformation over time post-ADT was categorized into early, linear, and late response phases. Dosimetric outcomes were analyzed across scenarios with varying prostate volume reduction magnitudes and different intervals between ADT initiation and brachytherapy. RESULTS: When ADT was initiated concurrently with brachytherapy, the model predicted substantial dose escalation if prostate shrinkage occurred early (prostate D90 ∼206 Gy; urethral V200 ∼47.7%) compared to late shrinkage response (D90 ∼183 Gy; V200 ∼7.1%). In contrast, separating the treatments in time greatly mitigated this effect. For example, assuming early response, performing brachytherapy 3 months before ADT yielded a prostate D90 of ∼183.0 Gy (urethral V200 ∼7.7%), while delaying brachytherapy to 3 months after ADT yielded a D90 of ∼177.8 Gy (V200 ∼1.2%). CONCLUSIONS: Dosimetric analysis showed that greater prostate volume reduction, early ADT response, and concurrent ADT all corresponded to substantially increased doses to the prostate and urethra. Clinically, these findings underscore the importance of carefully planning the timing of ADT relative to brachytherapy to optimize target coverage and minimize unintended dose escalation to normal tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBrachytherapyAndrogen AntagonistsProstateHumansMaleRadiotherapy DosageRadiotherapy Planning, Computer-AssistedMagnetic Resonance ImagingAgedTreatment Outcome

Stichwörter der Autor:innen

Androgen deprivation therapyDeformable image registrationDosimetric impactHormone therapy responseLow-dose-rate prostate brachytherapyPrincipal component analysis

Substanzen

Androgen Antagonists

Autor:innen und Institutionen

  • Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, South Korea; Medical Physics and Biomedical Engineering Lab (MPBEL), Yonsei Uni…
  • Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Radiation Oncology, Gachon University Gil Medical Center, Incheon, South Korea.
  • Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: jjhmd@yuhs.ac.

Zitieren

APA

Yoon, Y., Kim, W., Shin, H. B., Kim, J., & Cho, J. (2026). Dosimetric impact of androgen deprivation therapy (ADT)-induced prostate deformation in low-dose-rate prostate brachytherapy. Brachytherapy. https://doi.org/10.1016/j.brachy.2025.11.006

Vancouver

Yoon Y, Kim W, Shin HB, Kim J, Cho J. Dosimetric impact of androgen deprivation therapy (ADT)-induced prostate deformation in low-dose-rate prostate brachytherapy. Brachytherapy. 2026. doi:10.1016/j.brachy.2025.11.006

BibTeX
@article{Yoon2026,
  author = {Yoon, Younghun and Kim, Wooshik and Shin, Han-Back and Kim, Jihun and Cho, Jaeho},
  title = {Dosimetric impact of androgen deprivation therapy (ADT)-induced prostate deformation in low-dose-rate prostate brachytherapy},
  journal = {Brachytherapy},
  year = {2026},
  doi = {10.1016/j.brachy.2025.11.006}
}
Kostenlos starten →